Dr. Douglas Andrew Darbro, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5693 S Bear Wallow Rd, Suite 100, Morgantown, IN 46160 Phone: 765-342-9947 |
News Archive
Results from two concurrent, prospective, double-blind, multi-center clinical trials show that pegaptanib (Macugen), an anti-vascular endothelial growth factor therapy, is an effective treatment for neovascular age-related macular degeneration (AMD), according to a paper in the Dec. 30 issue of the New England Journal of Medicine. Macugen was approved by the Food and Drug Administration on Dec. 17.
Researchers from the Walter and Eliza Hall Institute have for the first time identified a 'programmed cell death' pathway in parasitic worms that could one day lead to new treatments for one of the world's most serious and prevalent diseases.
Arizona-based Critical Path Institute is pleased to announce it has been awarded a multi-year grant by the U.S. Food and Drug Administration to advance standards and methodologies designed to generate real-world evidence from real-world data through a neonatal pilot project through the International Neonatal Consortium.
Functional magnetic resonance imaging (fMRI) is a powerful noninvasive tool for studying brain activity in both humans and experimental animals.
› Verified 5 days ago